Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
KPRX: Kiora Pharmaceuticals, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
KPRX
The Story
KPRX
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
-100.0% / yr
Operating margin
0.0%
ROIC
-62.0%
Financially safe
Stretched
Debt / equity
0.03×
Interest coverage
0.0×
Current ratio
6.68×
Kiora Pharmaceuticals, Inc.
KPRX
NASDAQ Capital Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Kiora Pharmaceuticals, Inc.
KPRX
NASDAQ
·
USD
·
Closed
$2.56
+0.20%
$2.56
+$0.00 (0.20%)
52W Range
64th
pctl
Volume
0.12×
avg
Mkt Cap
11.35M
USD
P/E
-1.0
TTM
Div Yield
–
ann
52W Range
64th
pctl
Volume
0.12×
avg
Market Cap
11.35M
USD
P/E Ratio
-1.0
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings